发明公开
EP2376427A1 CRYSTALLINE FORMS OF A 3-CARBOXYPROPYL-AMINOTETRALIN COMPOUND 有权
3-羧基丙氨酰氨基甲酸酯化合物的结晶形式

  • 专利标题: CRYSTALLINE FORMS OF A 3-CARBOXYPROPYL-AMINOTETRALIN COMPOUND
  • 专利标题(中): 3-羧基丙氨酰氨基甲酸酯化合物的结晶形式
  • 申请号: EP09793383.2
    申请日: 2009-12-09
  • 公开(公告)号: EP2376427A1
    公开(公告)日: 2011-10-19
  • 发明人: DALZIEL, SeanRAPTA, Miroslav
  • 申请人: Theravance, Inc.
  • 申请人地址: 901 Gateway Boulevard South San Francisco, CA 94080 US
  • 专利权人: Theravance, Inc.
  • 当前专利权人: Theravance, Inc.
  • 当前专利权人地址: 901 Gateway Boulevard South San Francisco, CA 94080 US
  • 代理机构: Scott, Susan Margaret
  • 优先权: US121254P 20081210
  • 国际公布: WO2010068649 20100617
  • 主分类号: C07C231/24
  • IPC分类号: C07C231/24 C07C237/48
CRYSTALLINE FORMS OF A 3-CARBOXYPROPYL-AMINOTETRALIN COMPOUND
摘要:
The invention provides crystalline solid forms of (S)-4-((2S,3S)-7-carbamoyl-1,1-diethyl-3-methoxy-1,2,3,4-tetrahydronaphthalen-2-ylamino)-2-cyclohexylmethyl-butyric acid. The invention also provides pharmaceutical compositions comprising such crystalline solid forms, methods of using such crystalline solid forms to treat diseases associated with mu opioid receptor activity, and processes useful for preparing such crystalline solid forms.
公开/授权文献
信息查询
0/0